desicon

Why I Bought Abbott Laboratories Despite Health Care Reform

Pharmaceuticals are like utilities these days. With looming Obamacare, price regulations and general negative political climate there won’t be much investment going into developing new drugs instead the focus will be on cost management and acquisitions. It is foolhardy to value them as pharmaceuticals and make investment decisions.